[1]Humphrey, “Histological variants of prostatic carcinoma and their significance,” Histopathology. 2012.
[2]Humphrey et al., “The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours,” Eur. Urol., vol. 70, no. 1, pp. 106–119, 2016.
[3]Parimi et al., “Neuroendocrine differentiation of prostate cancer: a review.,” Am. J. Clin. Exp. Urol., vol. 2, no. 4, pp. 273–85, 2014.
[4]He, “Diagnosis of prostatic neuroendocrine carcinoma: Two cases report and literature review,” World J. Radiol., vol. 7, no. 5, p. 104, 2015.
[5]Musser et al., “Adult prostate sarcoma: The memorial sloan kettering experience,” Urology, vol. 84, no. 3, pp. 624–628, 2014.
[6]Li et al., “Beyond prostate adenocarcinoma: Expanding the differential diagnosis in prostate pathologic conditions,” Radiographics, vol. 36, no. 4, pp. 1055–1075, 2016.
[7]Chang et al., “Unusual tumours involving the prostate: Radiological-pathological findings,” Br. J. Radiol., vol. 81, no. 971, pp. 907–915, 2008.
[8]Altay et al., “Magnetic Resonance Imaging Features of Prostate Mucinous Adenocarcinoma,” J. Urol. Surg., vol. 5, no. 2, pp. 140–142, 2018.
[9]Osunkoya, “Mucinous and secondary tumors of the prostate,” Mod. Pathol., vol. 31, no. S1, pp. S80–S95, 2018.
[10]Yamada et al., “MRI features of mucinous adenocarcinoma of the prostate: report of four cases,” Abdom. Radiol., vol. 44, no. 4, pp. 1261–1268, Apr. 2019.
[11]Yu et al., “Prostate cancer and its mimics at multiparametric prostate MRI,” Br. J. Radiol., vol. 87, no. 1037, pp. 1–7, 2014.
[12]Bour et al., “Multiparametric MRI features of granulomatous prostatitis and tubercular prostate abscess,” Diagn. Interv. Imaging, vol. 94, no. 1, pp. 84–90, 2013.
[13]Rosenkrantz and Taneja, “Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI.,” AJR. Am. J. Roentgenol., vol. 202, no. 1, pp. 109–20, Jan. 2014.